XC Ortho Insights

Launching a private-label orthopedic line used to mean one of two bad options: commit to a huge first order (and pray you can move inventory), or spend months stuck because you don’t have drawings, packaging files, or a clear compliance plan. A low-MOQ pilot changes the math. Instead of betting on volume, you validate the supplier, the documentation, and your market demand with a controlled first run.

Most distributor teams don’t miscalculate ROI because they’re bad at math. They miscalculate it because they’re using the wrong unit of analysis. If you’re evaluating orthopedic suppliers by first-order margin (your gross margin on the first PO), you’re not measuring ROI. You’re measuring a single snapshot of unit economics—while the risks that actually make or break distributor profitability live in the months that follow.

Vertebral compression fractures (VCFs) in middle-aged and elderly patients often present a dual challenge: the need for immediate structural restoration and the difficulty of achieving secure fixation in osteoporotic or degenerative bone. This case study explores the successful application of the XC Medico MIS 5.5 System Cement Augmented Fenestrated Screw in a clinical setting in Chile.